12 reports

Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at aCAGR of 4% over...

  • Tropical Disease
  • Diagnostics
  • World
  • China
  • United States

##.## Tropical Disease Testing

  • Point Of Care Testing
  • North America
  • Drug Approval
  • Laboratory Revenue

##.## Increasing government funding for the use of POC in tropical disease testing will support market growth

  • Diagnostics
  • World
  • North America
  • Latin America
  • Drug Approval
  • Diabetes Prevalence

Biomeme will supply its mobile molecular point-of- need testing technology Franklin qPCR thermocycler and reagents to diagnose neglected tropical diseases (NTDs) and other infectious diseases like COVID-##.

  • Healthcare
  • Molecular Diagnostics
  • Healthcare IT
  • Application
  • World
  • North America
  • Europe
  • APAC
  • Health Expenditure
  • Drug Approval

Society of Infectious and Tropical Diseases

  • Blood Supply
  • Household Refrigerator
  • Laboratory
  • North America
  • United States
  • Canada
  • Mexico
  • Household Refrigerator Sales
  • Energy Consumption

In 2017, the GHIT received USD ## million in funding, part of which is expected to be used to develop new diagnostics for infectious diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases (NTDs).

  • Diagnostics
  • United States
  • Europe
  • APAC
  • North America
  • Infectious Disease Incidence
  • Health Expenditure

Tropical Diseases

  • Infectious Disease
  • Diagnostics
  • World
  • United States
  • Europe
  • APAC
  • North America
  • Health Expenditure
  • Drug Approval

Jan ##: BIOASTER awarded Grant for the development of rapid diagnostics for neglected tropical diseases

  • Infectious Disease
  • Diagnostics
  • Clinical Trial
  • United Kingdom
  • Senegal
  • United States
  • West Africa
  • Hospital Admission
  • Medical Devices Sales

This funding reimburses costs incurred during R&D. In 2017, the GHIT received USD ## million in funding, part of which is expected to be used to develop new diagnostics for infectious diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases (NTDs).

  • In Vitro Diagnostic Reagent
  • China
  • United States
  • APAC
  • Europe
  • North America
  • Health Expenditure
  • Infectious Disease Incidence

The initial focus is on developing rapid diagnostic tests to identify and distinguish specific neglected tropical diseases from each other and to create a superior next generation HIV test.

  • In Vitro Diagnostics
  • World
  • United States
  • Cervical Cancer Screening Coverage
  • Diagnostic Revenue

The field study is a collaboration with the BIDMC-based Harvard Medical School AIDS Initiative in Vietnam and the Hospital of Tropical Diseases in Ho Chi Minh City.

  • Diagnostics
  • Massachusetts
  • Medical Devices Sales

FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions.

  • Diagnostics
  • Clinical Trial
  • United States
  • World
  • Europe
  • North America
  • California
  • Ireland
  • Bulgaria
  • Termination Of Pregnancy
  • Cervical Cancer Screening Coverage